Ftse Mib
33.260,13
0,00%
DAX
19.425,73
0,85%
S&P 500
5.998,74
-0,38%
NASDAQ
19.060,48
-0,60%
Bitcoin
96.284,54
0,66%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX Cel Sci Corporation New (CVM) Cel Sci Corporation New (CVM) Notizie

Cel Sci Corporation New

CVM
0,616
0,00 (0,00%)
27 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: AMEX
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
15/11/202422:30EDGAR2Form 8-K - Current report
13/11/202414:30EDGAR2Form 8-K - Current report
08/11/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
07/11/202414:15BWU.S. FDA and CEL-SCI Agree on Use of PD-L1 Biomarker to..
30/10/202422:21EDGAR2Form S-3/A - Registration statement under Securities Act of..
25/10/202423:17EDGAR2Form S-3 - Registration statement under Securities Act of..
22/10/202415:15BWFDA’s Oncologic Drugs Advisory Committee Decision on..
10/10/202422:05EDGAR2Form AW - Amendment Withdrawal Request
01/10/202415:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/10/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/10/202414:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/10/202412:00BWCEL-SCI Selects Ergomed as CRO as it Gears Up for..
16/9/202413:30BWCEL-SCI’s Multikine® Increased 5-Year Survival Rate to 82.6%..
10/9/202415:32BWCEL-SCI to Present New Data for Multikine® Head & Neck..
04/9/202415:00BWThe UK’s Medicines & Healthcare Products Regulatory Agency..
30/8/202422:32EDGAR2Form S-8 - Securities to be offered to employees in employee..
15/8/202414:00BWCEL-SCI Corporation Reports Third Quarter Fiscal 2024..
14/8/202422:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
29/7/202423:16EDGAR2Form 8-K - Current report
29/7/202422:05BWCEL-SCI Announces Closing of $10.8 Million Offering
29/7/202413:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
26/7/202423:27EDGAR2Form 8-K - Current report
26/7/202417:52BWCEL-SCI Announces Pricing of $10.8 Million Offering
26/7/202414:23BWCEL-SCI’s Phase 3 Population Analysis for Upcoming..
08/7/202415:15BWCEL-SCI Appoints Robert Watson as Chairperson of the Board
18/6/202414:00BWCEL-SCI Presents Head & Neck Cancer Data at Iddst Annual..
06/6/202413:00BWDr. Giovanni Selvaggi, Who Has Brought Several Oncology..
16/5/202415:00BWCEL-SCI Corporation Reports Second Quarter Fiscal 2024..
15/5/202422:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/5/202415:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202419:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202415:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/5/202415:00BWCEL-SCI Receives FDA Go-Ahead for Its Confirmatory Study of..
23/4/202415:00BWCEL-SCI Appoints Mario Gobbo to Its Board of Directors
19/3/202414:00BWCEL-SCI’s LEAPS Vaccine Offers Promising New Paradigm to..
07/3/202417:33EDGAR2Form ARS - Annual Report to Security Holders
06/3/202414:45BWCEL-SCI Corporation Issues Letter to Shareholders
15/2/202414:00BWCEL-SCI Corporation Reports First Quarter Fiscal 2024..
14/2/202422:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/2/202418:00BWCEL-SCI Announces Closing of $7.75 Million Public Offering..
09/2/202414:30BWCEL-SCI Announces Pricing of $7.75 Million Public Offering..
06/2/202415:00BWCEL-SCI Completes Commissioning of Its Multikine..
31/1/202415:00BWEuropean Medicines Agency Grants CEL-SCI a Waiver of Strict..
02/1/202415:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202415:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202415:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202322:01EDGAR2Form S-8 - Securities to be offered to employees in employee..
22/12/202314:00BWCEL-SCI Reports Fiscal 2023 Financial Results and Clinical &..
21/12/202322:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
04/12/202314:30BWUK’S National Institute for Health and Care Excellence..
Apertura: 0,601 Min: 0,60 Max: 0,6199
Chiusura: 0,616

La tua Cronologia

AMEX
CVM
Cel Sci
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network